Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organonitrogen Compounds
  6. Hydrazines and derivatives
  7. LY 288513, Tocris Bioscience™

LY 288513, Tocris Bioscience™

Catalog No. p-4783613 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Selective CCK2 antagonist

Selective CCK2 receptor antagonist (IC50 values are 16 and > 30,000 nM for CCK2 and CCK1 respectively). Displays anxiolytic and antipsychotic properties in vivo.

Chemical Identifiers

CAS 147523-65-7
Molecular Formula C22H18BrN3O2
Molecular Weight (g/mol) 436.309
InChI Key LMUQHXHWJWQXSD-PMACEKPBSA-N
Synonym unii-470gwp2ca0, 4s,5r-n-4-bromophenyl-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide, 4s,5r-n-4-bromophenyl-3-oxo-4,5-diphenylpyrazolidine-1-carboxamide, maybridge4_000682, 1-4,5-diphenyl-3-pyrazolidinone, 1-pyrazolidinecarboxamide, n-4-bromophenyl-3-oxo-4,5-diphenyl-, 4s,5r, 4s,5r-3-oxo-4,5-diphenyl-pyrazolidine-1-carboxylic acid 4-bromo-phenyl-amide, 3-oxo-4,5-diphenyl-pyrazolidine-1-carboxylic acid 4-bromo-phenyl-amide ly288513
PubChem CID 2802894
IUPAC Name (4S,5R)-N-(4-bromophenyl)-3-oxo-4,5-diphenylpyrazolidine-1-carboxamide
SMILES C1=CC=C(C=C1)C2C(N(NC2=O)C(=O)NC3=CC=C(C=C3)Br)C4=CC=CC=C4

Specifications

Quantity 10 mg
Formula Weight 436.3
Percent Purity >98%
Chemical Name or Material LY 288513

Safety and Handling

Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.